The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitisEric L. Simpson, Amy S. Paller, Brett King et al.|Journal of the American Academy of Dermatology|2020Cited by 181
Dupilumab in Adults With Moderate to Severe Atopic DermatitisLisa A. Beck, Arsalan Shabbir, Robert Bissonnette et al.|JAMA Dermatology|2024Cited by 64